Advertisement
Advertisement
e2v has signed a new multi-year contract with Accuray Inc. for the supply of compact modulators and magnetrons for its TomoTherapyHi-ArtSystem, used for the treatment of cancer.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the segment of the United States nonvascular interventional radiology device market with the fastest growth and greatest potential is ablation devices, comprising radiofrequency (RF) ablation, cryoablation and microwave ablation devices. The overall market will grow moderately to $295 million by 2017.
Get access to premium content and e-newsletters by registering on the web site. You can also subscribe to Microwave Journal magazine.